PBRM1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.419800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.985630E-01
Normal-vs-Stage2
8.728400E-02
Normal-vs-Stage3
1.024020E-02
Normal-vs-Stage4
8.251600E-01
Stage1-vs-Stage2
8.705800E-01
Stage1-vs-Stage3
9.425600E-02
Stage1-vs-Stage4
3.473400E-01
Stage2-vs-Stage3
8.166100E-02
Stage2-vs-Stage4
1.243600E-01
Stage3-vs-Stage4
9.692300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.801500E-02
Normal-vs-AfricanAmerican
5.546400E-01
Normal-vs-Asian
6.008200E-02
Caucasian-vs-AfricanAmerican
2.877600E-01
Caucasian-vs-Asian
3.796000E-01
AfricanAmerican-vs-Asian
2.382400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.365700E-02
Normal-vs-Female
9.872200E-02
Male-vs-Female
6.917800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.150020E-01
Normal-vs-Age(41-60Yrs)
2.443200E-01
Normal-vs-Age(61-80Yrs)
5.379700E-02
Normal-vs-Age(81-100Yrs)
2.779800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.744000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.868800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.391000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.803900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.560100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.845000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.493700E-02
Normal-vs-Daily Drinker
9.623900E-03
Normal-vs-Weekly Drinker
3.445700E-02
Normal-vs-Occasional Drinker
1.851840E-01
Normal-vs-Social Drinker
3.440000E-01
Non Drinker-vs-Daily Drinker
3.874800E-01
Non Drinker-vs-Weekly Drinker
8.774600E-01
Non Drinker-vs-Occasional Drinker
2.087000E-01
Non Drinker-vs-Social Drinker
3.149400E-01
Daily Drinker-vs-Weekly Drinker
3.729000E-01
Daily Drinker-vs-Occasional Drinker
6.256000E-02
Daily Drinker-vs-Social Drinker
1.405430E-01
Weekly Drinker-vs-Occasional Drinker
3.556200E-01
Weekly Drinker-vs-Social Drinker
3.926000E-01
Occasional Drinker-vs-Social Drinker
9.066600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.637600E-01
Normal-vs-Grade 2
1.150810E-01
Normal-vs-Grade 3
1.360610E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.379000E-01
Grade 1-vs-Grade 3
5.762800E-01
Grade 1-vs-Grade 4
2.637600E-01
Grade 2-vs-Grade 3
8.097600E-01
Grade 2-vs-Grade 4
1.150810E-01
Grade 3-vs-Grade 4
1.360610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.205900E-02
Normal-vs-NonDiabetic
3.717700E-02
Diabetic-vs-NonDiabetic
7.092000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.261100E-03
Normal-vs-NoPancreatitis
5.170000E-02
Pancreatitis-vs-NoPancreatitis
2.734800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.182640E-01
Normal-vs-N1
8.602300E-02
N0-vs-N1
7.323400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.709020E-01
Normal-vs-TP53-NonMutant
1.844610E-01
TP53-Mutant-vs-TP53-NonMutant
9.802000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
